Literature DB >> 32030107

Cell Communication Network Factor 4 (CCN4/WISP1) Shifts Melanoma Cells from a Fragile Proliferative State to a Resilient Metastatic State.

Wentao Deng1,2, Audry Fernandez1,2, Sarah L McLaughlin2,3, David J Klinke1,2,4.   

Abstract

INTRODUCTION: Cellular communication network factor 4 (CCN4/WISP1) is a secreted matricellular protein that stimulates metastasis in multiple malignancies but has an unclear impact on phenotypic changes in melanoma. Recent data using cells edited via a double-nickase CRISPR/Cas9 approach suggest that CCN4/WISP1 stimulates invasion and metastasis of melanoma cells. While these data also suggest that loss of CCN4/WISP1 increases cell proliferative, the CRISPR approach used may be an alternative explanation rather than the loss of gene function.
METHODS: To test whether CCN4/WISP1 also influences the proliferative phenotype of melanoma cells, we used mouse melanoma models and knocked out Ccn4 using a homology-directed repair CRISPR/Cas9 system to generate pools of Ccn4-knockout cells. The resulting edited cell pools were compared to parental cell lines using an ensemble of in vitro and in vivo assays.
RESULTS: In vitro assays using knockout pools supported previous findings that CCN4/WISP1 promoted an epithelial-mesenchymal-like transition in melanoma cells and stimulated invasion and metastasis. While Ccn4 knockout also enhanced cell growth in optimal 2D culture conditions, the knockout suppressed certain cell survival signaling pathways and rendered cells less resistant to stress conditions. Tumor cell growth assays at sub-optimal conditions in vitro, quantitative analysis of tumor growth assays in vivo, and transcriptomics analysis of human melanoma cell lines were also used to quantify changes in phenotype and generalize the findings.
CONCLUSIONS: In addition to stimulating invasion and metastasis of melanoma cells, the results suggested that CCN4/WISP1 repressed cell growth and simultaneously enhanced cell survival. © Biomedical Engineering Society 2019.

Entities:  

Keywords:  Apoptosis; Epithelial-mesenchymal transition; Invasion; Metastasis; Survival; Tumor growth

Year:  2019        PMID: 32030107      PMCID: PMC6981335          DOI: 10.1007/s12195-019-00602-2

Source DB:  PubMed          Journal:  Cell Mol Bioeng        ISSN: 1865-5025            Impact factor:   2.321


  38 in total

1.  Wnt1 inducible signaling pathway protein 1 (WISP1) blocks neurodegeneration through phosphoinositide 3 kinase/Akt1 and apoptotic mitochondrial signaling involving Bad, Bax, Bim, and Bcl-xL.

Authors:  Shaohui Wang; Zhao Zhong Chong; Yan Chen Shang; Kenneth Maiese
Journal:  Curr Neurovasc Res       Date:  2012-02       Impact factor: 1.990

2.  WISP-1 binds to decorin and biglycan.

Authors:  L Desnoyers; D Arnott; D Pennica
Journal:  J Biol Chem       Date:  2001-10-11       Impact factor: 5.157

3.  WISP-1 is a Wnt-1- and beta-catenin-responsive oncogene.

Authors:  L Xu; R B Corcoran; J W Welsh; D Pennica; A J Levine
Journal:  Genes Dev       Date:  2000-03-01       Impact factor: 11.361

4.  Unexpected mutations after CRISPR-Cas9 editing in vivo.

Authors:  Kellie A Schaefer; Wen-Hsuan Wu; Diana F Colgan; Stephen H Tsang; Alexander G Bassuk; Vinit B Mahajan
Journal:  Nat Methods       Date:  2017-05-30       Impact factor: 28.547

Review 5.  WNT1 inducible signaling pathway protein 1 (WISP1): a novel mediator linking development and disease.

Authors:  Barbara Berschneider; Melanie Königshoff
Journal:  Int J Biochem Cell Biol       Date:  2010-11-23       Impact factor: 5.085

6.  Cancer statistics, 2016.

Authors:  Rebecca L Siegel; Kimberly D Miller; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2016-01-07       Impact factor: 508.702

7.  Wnt-induced secreted protein-1 is a prohypertrophic and profibrotic growth factor.

Authors:  J T Colston; S D de la Rosa; M Koehler; K Gonzales; R Mestril; G L Freeman; S R Bailey; B Chandrasekar
Journal:  Am J Physiol Heart Circ Physiol       Date:  2007-07-06       Impact factor: 4.733

8.  WNT1-inducible signaling pathway protein-1 activates diverse cell survival pathways and blocks doxorubicin-induced cardiomyocyte death.

Authors:  Balachandar Venkatesan; Sumanth D Prabhu; Kaliyamurthi Venkatachalam; Srinivas Mummidi; Anthony J Valente; Robert A Clark; Patrice Delafontaine; Bysani Chandrasekar
Journal:  Cell Signal       Date:  2010-01-13       Impact factor: 4.315

9.  Expression of the Elm1 gene, a novel gene of the CCN (connective tissue growth factor, Cyr61/Cef10, and neuroblastoma overexpressed gene) family, suppresses In vivo tumor growth and metastasis of K-1735 murine melanoma cells.

Authors:  Y Hashimoto; N Shindo-Okada; M Tani; Y Nagamachi; K Takeuchi; T Shiroishi; H Toma; J Yokota
Journal:  J Exp Med       Date:  1998-02-02       Impact factor: 14.307

Review 10.  Melanoma cells revive an embryonic transcriptional network to dictate phenotypic heterogeneity.

Authors:  Niels Vandamme; Geert Berx
Journal:  Front Oncol       Date:  2014-12-09       Impact factor: 6.244

View more
  4 in total

1.  Cell Communication Network factor 4 promotes tumor-induced immunosuppression in melanoma.

Authors:  Audry Fernandez; Wentao Deng; Sarah L McLaughlin; Anika C Pirkey; Stephanie L Rellick; Atefeh Razazan; David J Klinke
Journal:  EMBO Rep       Date:  2022-01-31       Impact factor: 8.807

2.  Data-driven learning how oncogenic gene expression locally alters heterocellular networks.

Authors:  David J Klinke; Audry Fernandez; Wentao Deng; Atefeh Razazan; Habibolla Latifizadeh; Anika C Pirkey
Journal:  Nat Commun       Date:  2022-04-13       Impact factor: 17.694

3.  An Unsupervised Strategy for Identifying Epithelial-Mesenchymal Transition State Metrics in Breast Cancer and Melanoma.

Authors:  David J Klinke; Arezo Torang
Journal:  iScience       Date:  2020-04-22

4.  Proteasomal degradation of polycomb-group protein CBX6 confers MMP-2 expression essential for mesothelioma invasion.

Authors:  Katsuya Sakai; Takumi Nishiuchi; Shoichiro Tange; Yoshinori Suzuki; Seiji Yano; Minoru Terashima; Takeshi Suzuki; Kunio Matsumoto
Journal:  Sci Rep       Date:  2020-10-07       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.